On December 5th, the grand "2023 Zhejiang Venture Investment Summit and Zhejiang Capital and Innovation Merger Conference" concluded successfully in Hangzhou. Hosted by Department of Science and Technology of Zhejiang Province and co-organized by Zhejiang Venture Capital Association and the Hangzhou Branch of China Everbright Bank Co., Ltd., the event brought together leading figures from across the venture capital and innovation landscape.During the summit, the highly anticipated "2023 Zhejiang Venture Capital Annual Rankings" were officially released with great fanfare. At the ceremony, Westlake Pharmaceuticals emerged triumphant, ranking among the esteemed " Zhejiang's Most Investment Valuable Innovative Enterprises TOP50 ".

Under the banner of "Focusing on High-quality Development to Drive New Momentum in Venture Capital", esteemed dignitaries graced the occasion, including Mao Guanglie, former Deputy Secretary of the Party Committee and Vice Director of the Standing Committee of Zhejiang Provincial People's Congress and Honorary President of Zhejiang Venture Capital Association, and Qiu Feizhang, who served as the former Deputy Secretary of the Party Committee and Vice Director of Department of Science and Technology of Zhejiang Province and now President of Zhejiang Venture Capital Association, Zhou Tufa, the Party Committee Member and Vice Director of Department of Science and Technology of Zhejiang Province ,

Fu Wenjun, Head of Finance and Fiscal Affairs Bureau of Zhejiang Provincial Development and Reform Commission, and Shi Feng, fulfilling the same role at Hangzhou Municipal Development and Reform Commission, along with Zheng Jun, Chairman of Zhejiang Financial Holdings Investment Management Co., Ltd. The event further attracted over 350 participants representing various venture capital entities and technology-driven enterprises.

The "2023 Zhejiang Venture Capital Annual Rankings", initiated by Rongzhong, were ceremoniously announced at the event. The rankings featured two distinct segments: the "Zhejiang's Most Investment Valuable Innovative Enterprises TOP50 for 2023

" and the "Zhejiang Venture Capital Institutions TOP50 for 2023". A rigorous multi-stage process characterized the awards, commencing with the initiation of the selection process, followed by the registration of candidate institutions, comprehensive data collection, and thorough result assessments. Upholding the highest standards of equity, impartiality, and openness throughout the event, the definitive rankings were derived from the fiscal data furnished by the competing institutions for the period between 2022 and 2023, augmented by meticulous scrutiny from a panel of esteemed experts.

During the afternoon session of the "2023 Zhejiang Venture Capital and Innovation Achievement Matching Conference," West lake Pharmaceuticals, representing outstanding science and technology innovation enterprises, presented a pitch. Dr. Liang Dongdong, the company's Chief Operating Officer, delivered a project showcase entitled "R&D and Industrialization of Novel Small Molecule Drugs Originating from Innovation." The project garnered significant attention and resounding affirmation from the on-site guest reviewers.

Being listed among the honorees signifies the recognition from the event organizers and judges of Westlake Pharmaceuticals' achievements over the past few years, serving as a powerful impetus for the company's ongoing progress. Westlake Pharmaceuticals remains committed to its founding mission, forging ahead steadfastly towards high-quality development, and striving to create greater social value.